Article Sidebar

Submitted
May 20, 2025
Published
May 20, 2025
Download
PDF
Statistic
Read Counter : 28 Download : 14

Main Article Content

Abstract

Millions of people worldwide are still impacted by breast cancer, a complicated and common health issue. This review article offers a thorough examination of the complex field of breast cancer, clarifying the wide range of risk factors that contribute to its development and investigating developments in diagnostic techniques. Millions of people worldwide are still impacted by breast cancer, a complicated and common health Numerous risk factors, including genetic predispositions such BRCA mutations, hormonal impacts, lifestyle factors, and reproductive patterns, have been found through a thorough review of recent literature. The complex aetiology of breast cancer is further influenced by environmental variables, age, and family history.New technologies like magnetic resonance imaging and molecular testing complement mammography, the mainstay of breast cancer screening, to increase the sensitivity and specificity of breast cancer diagnosis. Despite these developments, it is still difficult to guarantee that screening programs are widely accessible, especially in environments with low resources. This review concludes by highlighting the significance of comprehending the various risk factors that contribute to the development of breast cancer and the vital role that developing diagnostic techniques play in improving early detection. The critical significance that diagnostic technologies play in the early diagnosis and treatment of breast cancer is also outlined in this review.

Keywords

Hematoxylin Diagnostic

Article Details

How to Cite
Shaik parveen, M. Rishitha, M. Pavani, & M. Gayathri. (2025). Histopathological Analysis of Breast Cancer Using Hematoxylin and Eosin Staining: Diagnostic and Prognostic Insights. International Journal of Research in Pharmacology & Pharmacotherapeutics, 14(2), 363-367. Retrieved from https://ijrpp.com/ijrpp/article/view/670
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Obeagu EI, Babar Q, Vincent CC, et al. Therapeutic targets in breast cancer signaling: a review. J Pharm Res Int. 2021;33:82–99.
  2. 2. Aizaz M, Khan M, Khan FI, et al. Burden of breast cancer: developing countries perspective. Int J Innov Appl Res. 2023;11:31–7.
  3. 3. Ibekwe AM, Obeagu EI, Ibekwe CE, et al. Challenges of exclusive breastfeeding among working class women in a teaching hospital South East, Nigeria. J Pharm Res Int. 2022;34:1.
  4. 4. Sun YS, Zhao Z, Yang ZN, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13:1387–97.
  5. 5. Sinha T. Tumors: benign and malignant. Cancer Ther Oncol Int J. 2018;10:555790.
  6. 6. Edward U, Obeagu EI, Okorie HM, et al. Studies of serum calcium, inorganic phosphate, a d magnesium levels in lactating mothers in Owerri. J Pharm Res Int. 2021;33:209–16.
  7. 7. Obeagu EI, Ahmed YA, Obeagu GU, et al. Biomarkers of breast cancer: overview. Int J Curr Res Biol Med. 2023;8:8–16.
  8. 8. Iatrakis G, Zervoudis S. Epidemiology of ductal carcinoma in situ. Chirurgia (Romania). 2021;116(5 Suppl):S15–S21.
  9. 9. Jagsi R, Mason G, Overmoyer BA, et al. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Res Treat. 2022;192:235–43.
  10. 10. Pedersen RN, Esen BO, Mellemkjær L, et al. The incidence of breast cancer recurrence 10-32 years after primary diagnosis. J Natl Cancer Inst. 2022;114:391–99.
  11. 11. Hu X, Zhang Q, Xing W, et al. Role of microRNA/lncRNA intertwined with the Wnt/β-Catenin axis in regulating the pathogenesis of triple-negative breast cancer. Front Pharmacol. 2022;13:814971.
  12. 12. Thigpen D, Kappler A, Brem R. The role of ultrasound in screening dense breasts—a review of the literature and practical solutions for implementation. Diagnostics. 2018;8:20.
  13. 13. Vatankhah H, Khalili P, Vatanparast M, et al. Prevalence of early and late menopause and its determinants in Rafsanjan cohort study. Sci Rep. 2023;13:1847.
  14. 14. Garnæs KK, Elvebakk T, Salvesen O, et al. Dietary intake in early pregnancy and glycemia in late pregnancy among women with obesity. Nutrients. 2022;14:1015.
  15. 15. Mills ZB, Faull RLM, Kwakowsky A. Is hormone replacement therapy a risk factor or a therapeutic option for Alzheimer’s disease? Int J Mol Sci. 2023;24:3205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. 16. Kunyahamu MS, Daud A, Jusoh N. Obesity among health-care workers: which occupations are at higher risk of being obese? Int J Environ Res Public Health. 2021;18:4381.
  17. 17. Belachew EB, Sewasew DT. Molecular mechanisms of endocrine resistance in estrogen-positive breast cancer. Front Endocrinol. 2021;12:689705.
  18. 18. Heer E, Ruan Y, Mealey N, et al. The incidence of breast cancer in Canada 1971-2015: trends in screening-eligible and young-onset age groups. Can J Public Health. 2020;111:787–93.
  19. 19. Van Ourti T, O’Donnell O, Koç H, et al. Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from the rollout of the Dutch population-based program with 17-year follow-up of a cohort. Int J Cancer. 2020;146:2201–8. [DOI]
  20. 20. Buist DSM, Abraham L, Lee CI, et al. Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med. 2018;178:458–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. 21. Maio F, Tari DU, Granata V, et al. Breast cancer screening during COVID-19 emergency: patients and department management in a local experience. J Pers Med. 2021;11:380.
  22. 22. Li MR, Liu MZ, Ge YQ, et al. Assistance by routine CT features combined with 3D texture analysis in the diagnosis of BRCA gene mutation status in advanced epithelial ovarian cancer. Front Oncol. 2021;11:696780.